| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-09 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-08 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |